Bluebird bio Inc (NASDAQ: BLUE) is -71.70% lower on its value in year-to-date trading and has touched a low of $0.34 and a high of $5.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BLUE stock was last observed hovering at around $0.41 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.39, the stock is -15.98% and -21.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.35 million and changing -3.63% at the moment leaves the stock -57.58% off its SMA200. BLUE registered -86.89% loss for a year compared to 6-month loss of -63.50%. The firm has a 50-day simple moving average (SMA 50) of $0.5014 and a 200-day simple moving average (SMA200) of $0.9245.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -22.39% gain in the last 1 month and extending the period to 3 months gives it a -52.07%, and is -13.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.57% over the week and 6.95% over the month.
Bluebird bio Inc (BLUE) has around 375 employees, a market worth around $75.74M and $54.90M in sales. Profit margin for the company is -553.28%. Distance from 52-week low is 15.80% and -92.94% from its 52-week high. The company has generated returns on investments over the last 12 months (-122.89%).
with sales reaching $18.05M over the same period.The EPS is expected to grow by 20.29% this year, but quarterly earnings will post 193.30% year-over-year.
Bluebird bio Inc (BLUE) Top Institutional Holders
200.0 institutions hold shares in Bluebird bio Inc (BLUE), with institutional investors hold 44.04% of the company’s shares. The shares outstanding are 192.77M, and float is at 192.36M with Short Float at 24.80%. Institutions hold 43.76% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 15.44 million shares valued at $15.2 million. The investor’s holdings represent 14.1544% of the BLUE Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.3 million shares valued at $10.14 million to account for 9.4422 of the shares outstanding. The other top investors are AMERIPRISE FINANCIAL INC which holds 6.39 million shares representing 5.8586% and valued at over $6.29 million, while MILLENNIUM MANAGEMENT LLC holds 4.7175 of the shares totaling 5.15 million with a market value of $5.07 million.
Bluebird bio Inc (BLUE) Insider Activity
The most recent transaction is an insider sale by Klima Thomas J. SEC filings show that Klima Thomas J sold 1,006 shares of the company’s common stock on Sep 30 ’24 at a price of $0.53 per share for a total of $529.0. Following the sale, the insider now owns 0.17 million shares.
Bluebird bio Inc disclosed in a document filed with the SEC on Sep 30 ’24 that Obenshain Andrew (President and CEO) sold a total of 34,780 shares of the company’s common stock. The trade occurred on Sep 30 ’24 and was made at $0.53 per share for $18270.0. Following the transaction, the insider now directly holds 0.38 million shares of the BLUE stock.
Still, SEC filings show that on Sep 30 ’24, Obenshain Andrew (Officer) Proposed Sale 34,780 shares at an average price of $0.52 for $18086.0. The insider now directly holds shares of Bluebird bio Inc (BLUE).
